The insider selling cluster is notable in size but appears driven by planned liquidity events (derivative exercises) rather than a coordinated bearish signal. Monitor for any upcoming earnings release or material corporate development that could explain the timing. The CCO's large sale following option exercises is a routine pattern and not inherently bearish.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 12 $165.11entry
- T+1 · 3mo ago −3.37%α −4.07% · $159.54
- T+5 · 3mo ago −1.07%α −0.63% · $163.34
- T+20 · 2mo ago −3.68%α −1.78% · $159.03
- T+60 · 12d ago +2.10%α +6.98% · $168.58
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Guardant Health directors sold shares in a cluster totaling $1.60M in open-market sales, with the CCO also executing a large derivative exercise and immediate sale of shares worth ~$10.8M. The total insider selling of ~$12.4M represents approximately 0.4% of market cap, a modest but notable amount. The cluster is amplified by the presence of a concurrent earnings context and a late-filing context, per cross-filing actuarial data, but the selling is primarily driven by C-suite and director liquidity events rather than a uniform bearish signal.
Key Financial Metrics
Key Facts
- CCO Chris Freeman exercised derivatives and sold 63,605 shares in open-market transactions totaling ~$10.8M on 2026-08-10
- Director Ian T. Clark sold 9,100 shares for $1.44M on 2026-08-04
- Director Manuel Hidalgo Medina sold 1,700 shares for ~$279K on 2026-08-05
- Total open-market insider selling in the cluster: ~$12.4M, or ~0.4% of market cap
- The cluster includes derivative exercises (non-cash) that funded the CCO's sales, indicating a planned liquidity event
Financial Impact
Total insider selling of ~$12.4M, representing ~0.4% of Guardant Health's market cap
Risk Factors
- Insider selling may signal management's lack of confidence in near-term stock performance
- The cluster's timing near a potential earnings or late-filing event could indicate undisclosed negative news
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GH-1786489280221 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers